When did Danaher close the Masimo acquisition?

The deal closed on June 14, 2026.

Danaher Completes Masimo Acquisition to Boost Diagnostics Portfolio

Q: What will Masimo add to Danaher's portfolio?

Masimo will add sensor technologies and AI-powered patient monitoring tools.

Danaher (NYSE:DHR) has completed its acquisition of Masimo, a company specializing in sensor technologies and patient monitoring. The deal aims to expand Danaher's healthcare technology solutions across hospitals and clinics.

June 14, 2026

2 min read

Source: Simply Wall St.

Danaher (NYSE:DHR) has completed its acquisition of Masimo, a move that deepens its position in diagnostics and patient monitoring. The deal adds Masimo's advanced sensor technologies and AI-powered patient monitoring tools to Danaher's existing portfolio.

Deal Details

Acquirer: Danaher (DHR)
Target: Masimo
Value: Not disclosed
Payment Method: Not disclosed
Closing Date: June 14, 2026

Rationale

Danaher aims to strengthen its diagnostics and patient monitoring capabilities, areas where healthcare providers are increasingly focused on data quality and workflow efficiency. Masimo's technologies will allow Danaher to offer integrated solutions including sensors and continuous monitoring.

Regulatory Challenges

No significant regulatory hurdles were reported, and the deal closed without apparent obstacles.

Impact on Stocks

The acquisition is expected to enhance Danaher's position in the healthcare market, potentially benefiting DHR stock in the long term. However, no immediate stock reaction was reported.

Frequently Asked Questions

The financial value of the deal was not disclosed in the source.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.